Doxylamine Succinate And Pyridoxine Hydrochloride Tablet, Delayed Release
Product Images NDC 70505-100

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Doxylamine Succinate And Pyridoxine Hydrochloride (NDC 70505-100). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Analog Pharma, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bottle Label-outside Front Cover With Imprint Area For Lot & Expiry (Bottle Label 1)

Bottle Label-outside Front Cover With Imprint Area For Lot & Expiry (Bottle Label 1)
Each tablet contains Donfanine Succivate and yidone Hyocloide. It's a delayed-release tablet and recommended dosage is one of four tablets daily. It should be stored at a temperature between 20°C to 26°C (68°F to 77°F) with excursions permitted between 16°C and 30°C (50°F and 86°F). It also has a warning to swallow the tablet whole. The given information is related to a medication with the product name W70505-100-10 and contains 100 delayed-release tablets. The provided NDC code "70505-100-10" refers to drug product "ANALOG", and it's available by a prescription only. The text does not provide any information about what the medication is used for or its potential side effects.*
FDA Label Image

Bottle Label – Inside Cover (Bottle Label Inside)

Bottle Label – Inside Cover (Bottle Label Inside)
This is a medication packaging for Doxylamine Succinate and Pyridoxin Hydrochloride. The storage instructions indicate that it should be stored at room temperature, and out of reach of children. The medication is a delayed-release tablet and should be swallowed whole without crushing or chewing. The package contains 100 tablets. For further information, healthcare professionals can request product information from Analog Pharma.*
FDA Label Image

Structure-1 (Structure 1)

FDA Label Image

Structure-2 (Structure 2)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.